Research output per year
Research output per year
Search results
-
2023
The biological basis for targeting protein turnover in malignant cells
Orłowski, R. Z., Apr 14 2023, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice. wiley, Vol. 1. p. 303-312 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
2013
Novel proteasome inhibitors
Orlowski, R. Z., Jan 1 2013, Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research. Springer New York, p. 157-180 24 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
1 Scopus citations -
2011
Bortezomib in relapsed and relapsed/ refractory multiple myeloma
Shah, J. J. & Orlowski, R. Z., 2011, Bortezomib in the Treatment of Multiple Myeloma. Ghobrial, I., Richardson, P. & Anderson, K. (eds.). p. 79-94 16 p. (Milestones in Drug Therapy; vol. 37).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
2010
Bortezomib in relapsed and relapsed/refractory multiple myeloma
Shah, J. J. & Orlowski, R. Z., 2010, Drugs for HER-2-positive Breast Cancer. Parnham, M. & Bruinvels, J. (eds.). p. 79-94 16 p. (Milestones in Drug Therapy).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
2005
Targeting the proteasome in cancer therapy
Orlowski, R. Z., 2005, Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. Springer US, p. 243-274 32 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter